Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $663.23 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $242.20 | 3 | $0 (2018) |
| PFIZER INC. | $235.85 | 6 | $0 (2017) |
| Celgene Corporation | $110.23 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $45.13 | 2 | $0 (2020) |
| Galderma Laboratories, L.P. | $29.82 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $29.82 | 2 | Galderma Laboratories, L.P. ($29.82) |
| 2020 | $21.16 | 1 | Regeneron Healthcare Solutions, Inc. ($21.16) |
| 2019 | $23.97 | 1 | Regeneron Healthcare Solutions, Inc. ($23.97) |
| 2018 | $219.85 | 2 | Amgen Inc. ($219.85) |
| 2017 | $368.43 | 8 | PFIZER INC. ($235.85) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2021 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ACNE | ||||||
| 05/24/2021 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: ACNE | ||||||
| 02/04/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2018 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $109.93 | General |
| Category: Inflammation | ||||||
| 02/08/2018 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $109.92 | General |
| Category: Inflammation | ||||||
| 08/24/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $109.68 | General |
| Category: DERMATOLOGY | ||||||
| 08/03/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $101.56 | General |
| Category: DERMATOLOGY | ||||||
| 07/25/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: DERMATOLOGY | ||||||
| 07/25/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: DERMATOLOGY | ||||||
| 06/21/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $110.23 | General |
| Category: Dermatology | ||||||
| 02/28/2017 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Inflammation | ||||||
| 02/07/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: DERMATOLOGY | ||||||
| 02/07/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: DERMATOLOGY | ||||||
About Samuel Fort
Samuel Fort is a Legal Medicine healthcare provider based in Salisbury, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841254166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samuel Fort has received a total of $663.23 in payments from pharmaceutical and medical device companies, with $29.82 received in 2021. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($663.23).
Practice Information
- Specialty Legal Medicine
- Location Salisbury, NC
- Active Since 04/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 173000000X
- Entity Type Individual
- NPI Number 1841254166
Products in Payments
- Enbrel (Biological) $242.20
- EUCRISA (Drug) $235.85
- Otezla (Drug) $110.23
- DUPIXENT (Biological) $45.13
- AKLIEF (Drug) $29.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.